$17.18 0.24 (+1.42%)
2/9/2010 4:00 PM

Genomic Health, Inc. (GHDX)

CAPS Rating: 5 out of 5

A life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions.

Current Price $17.18 Mkt Cap $491.53M
Open $16.99 P/E Ratio 2.83
Prev. Close $16.94 Div. (Yield) N/A (N/A)
Daily Range $16.80 - $17.32 Volume 105,226
52-Wk Range $15.81 - $27.22 Avg. Daily Vol. 0

GHDX News and Commentary

Caps

How do you think GHDX will perform vs the S&P 500?

Add Stock to Watchlist

All Members

168 Outperform
8 Underperform
 

All-Star Members

46 Outperform
2 Underperform
 

Wall Street

8 Outperform
1 Underperform
 

Top GHDX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.64)
Submitted May 10, 2009

Oncotype DX revenues for the last four quarters were 26, 28, 31 and 34 million respectively. The assay was also recently shown to be predictive of distant recurrence in colon cancer, although the market was apparently disappointed by its inability to… More

0 Comments | Reply | Report this Post

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

GHDX VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about GHDX.

Recs

0
Member Avatar bigrabbit66 (< 20) Submitted: 12/31/2009 3:03:31 PM : Outperform Start Price: $19.75 GHDX Score: -8.40

genomic signatures for cancer becoming more popular. beat earnings estimate significantly last time. just getting into profit 2010. Launching new signature for colon cancer.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar scoobamang (87.10) Submitted: 11/25/2009 10:52:00 PM : Outperform Start Price: $18.80 GHDX Score: -7.53

Revenue increasing at a very nice clip, about to climb out of the red and into profitability, nice cash cushion. Life science sounds sexy.

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar neilphipps (< 20) Submitted: 6/23/2009 4:31:02 PM : Outperform Start Price: $16.48 GHDX Score: -15.83

Genomics is a promising direction for genetic studies.

Report this Post 0 Comments | Reply | Permalink
View All 36 Pitches »

Leaderboard

Find the members with the highest scoring picks in GHDX.

Score Leader

tjnarumo

tjnarumo (95.58) Score: +66.39

The Score Leader is the member with the highest score across all their picks in GHDX.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
ezMarty < 20 9/6/2006 Outperform 5Y $11.84 +45.10% -12.22% +57.32
anticitradeshort 23.03 4/20/2009 Underperform NS $21.75 -21.01% +26.65% +47.66
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. dkelleher83 78.53 9/18/2006 Outperform 5Y $13.44 +27.83% -13.69% +41.52 4 Comments
MickeyJerry < 20 10/9/2006 Outperform 1Y $13.77 +24.76% -15.61% +40.37 1 Comment
Frannah < 20 9/20/2006 Outperform 3M $13.68 +25.58% -14.48% +40.07
tamvanta66 90.46 9/15/2006 Outperform 3Y $13.80 +24.49% -14.20% +38.69
ekrupnik < 20 10/5/2006 Outperform 3Y $14.06 +22.19% -15.63% +37.82
genericstockguy 38.17 9/14/2006 Outperform 3Y $13.81 +24.40% -13.27% +37.68 1 Comment
Ajebr < 20 10/9/2006 Outperform 1Y $14.10 +21.88% -15.68% +37.57 1 Comment
dbradywilson 38.60 9/13/2006 Outperform NS $13.98 +22.89% -13.15% +36.04
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackThinkEquity 64.82 1/8/2010 Outperform NS $18.01 -4.61% -5.93% +1.32
TrackZacks 62.21 11/6/2009 Underperform 3M $20.08 -14.44% +0.08% +14.53 1 Comment
TrackTWeisel < 20 6/11/2009 Outperform NS $18.27 -5.97% +14.55% -20.51
TrackMichaelBrus 92.73 2/14/2008 Outperform 1Y $23.34 -26.39% -17.33% -9.06
TrackRBCCapMkts 86.33 2/7/2008 Outperform NS $23.64 -27.33% -15.22% -12.11
TrackCantorFitz 31.61 2/6/2008 Outperform NS $23.14 -25.76% -16.97% -8.78
TrackCanaccord 86.15 1/29/2008 Outperform NS $22.17 -1.10% -6.78% +5.68 9/8/2008 @ $21.93
TrackLeerinkSwan 92.83 5/31/2007 Outperform NS $17.87 +39.12% -11.14% +50.26 1/17/2008 @ $24.86
TrackPiperJaff 85.79 3/27/2007 Outperform NS $17.91 -4.08% -20.80% +16.72
TrackRBCCapMkts 86.33 3/7/2007 Underperform NS $18.98 +19.81% +5.59% -14.22 12/21/2007 @ $22.74
TrackJimCramer < 20 11/21/2006 Outperform 3W $16.35 +5.08% -19.13% +24.21
TrackCantorFitz 31.61 11/7/2006 Outperform NS $16.66 +46.52% +10.42% +36.10 11/1/2007 @ $24.41
TrackJMP 71.98 11/6/2006 Outperform NS $15.38 +11.70% -16.91% +28.62

Featured Broker Partners